Acute hepatic dysfunction following. parenteral amiodarone administration Sir, We report a case in which intravenous administration of amiodarone was associated with acute deterioration of liver function.
A 59 year old man presented with a 2-week history of progressive congestive cardiac failure due to cardiomyopathy. On examination he was in uncontrolled atrial fibrillation, and had clinical and radiological signs of pulmonary congestion, and gross peripheral oedema. The liver was enlarged three fingerbreadths, and ultrasound examination confirmed hepatic congestion. His heart failure responded well to intravenous diuretics over the next 4 days, though bis ventricular response rate remained high despite digoxin. Liver function tests were mildly deranged on admission due to hepatic congestion but initially improved.
His atrial fibrillation remained difficult to control and amiodarone was started on day 6. He received 450mg intravenously for 5 days and 200 mg for a further 2 days. He became progressively morejaundiced following the administration of amiodarone despite a sustained improvement in the control of his heart failure. Liver function tests deteriorated with the aspartate transaminase rising to ten times the normal value (Figure 1 ). There was no evidence of haemolysis and repeat liver ultrasound showed mild hepatic congestion only with no signs of biliary obstruction. Heptatic serology and auto-antibody screen were negative. An 
